Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 9 Lung Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Gliosarcoma 7 Central Nervous System Neoplasms 7 Prostatic Neoplasms 5 Lymphoma 5 Breast Neoplasms 5 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Kidney Neoplasms 4 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Lymphoma, Non-Hodgkin 3 Head and Neck Neoplasms 3 Brain Neoplasms 3 Urogenital Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasms 2 Multiple Myeloma 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Large Cell 2 Adenocarcinoma of Lung 2

Interventions

Sorafenib 68 Bevacizumab 44 Oxaliplatin 25 Doxorubicin 22 Gemcitabine 21 Fluorouracil 21 Radiosurgery 20 Nivolumab 19 durvalumab 18 Radiofrequency Ablation 18 pembrolizumab 17 lenvatinib 17 Cisplatin 17 Capecitabine 17 atezolizumab 14 Leucovorin 14 Hepatectomy 14 Radiotherapy 12 tremelimumab 10 Irinotecan 10 Drug Therapy 10 Cyclophosphamide 10 Carboplatin 10 Blood Specimen Collection 10 Ipilimumab 9 regorafenib 8 Liver Transplantation 8 Everolimus 8 Cryosurgery 8 Chemotherapy, Adjuvant 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × motexafin gadolinium × Clear all

NCT01082224 2023-07-07

ACRIN6690

American College of Radiology Imaging Network

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡